-
Avanci responds to Chinese study on automotive SEP license fees: “numerous inaccuracies”
Read more: Avanci responds to Chinese study on automotive SEP license fees: “numerous inaccuracies”Context: Commonly, when Avanci announces something, it involves new licensors or licensees (see, e.g., this October 9, 2024 ip fray article). Avanci’s automotive pool covers a very high percentage of all 4G and 5G standard-essential patents (SEPs), and most of the market (which for 5G depends on whether companies are already implementing it) is licensed.…
-
AstraZeneca expands cancer drug patent enforcement campaign in U.S., seeks preliminary injunctions
Read more: AstraZeneca expands cancer drug patent enforcement campaign in U.S., seeks preliminary injunctionsAstraZeneca has filed four separate complaints against generic drugmakers Cipla, Sandoz, Natco, and Zydus in the United States District Court for the District of New Jersey.
-
Three attempts to use U.S. courts against German (or UPC) patent enforcement actions have failed in recent years: disproven recipe?
Read more: Three attempts to use U.S. courts against German (or UPC) patent enforcement actions have failed in recent years: disproven recipe?It has been tried three times over the past couple of years to leverage U.S. district courts against German courts or the UPC, and it produced nothing but costs.
-
NPE sues SK Hynix in Eastern District of Texas: alleges Dell, Microsoft and Nvidia also “indirectly” infringing semiconductor patents
Read more: NPE sues SK Hynix in Eastern District of Texas: alleges Dell, Microsoft and Nvidia also “indirectly” infringing semiconductor patentsAdvanced Memory Technologies LLC, represented by litigation powerhouse Susman Godfrey, has accused SK Hynix of infringing four semiconductor-related patents.
-
“Some say power over people… I say achieving through and with people”: an interview with Bayer’s IP head Dr. Jörg Thomaier
Read more: “Some say power over people… I say achieving through and with people”: an interview with Bayer’s IP head Dr. Jörg ThomaierIn this interview, Dr. Jörg Thomaier, CEO of Bayer IP GmbH, reflects on over 27 years at the pharma giant, including helping transform the patent team from being a somewhat “neglected child” into a respected, functioning engine for the overall company.
-
Public version of Nokia v. Amazon ITC ruling in multimedia SEP case holds e-commerce giant responsible for unlicensed status
Read more: Public version of Nokia v. Amazon ITC ruling in multimedia SEP case holds e-commerce giant responsible for unlicensed statusThe public redacted version of a trade judge’s December 2024 ruling shows that Amazon was far from prevailing over Nokia on a FRAND defense.
-
Catalyst and Teva Pharmaceuticals settle patent dispute over rare-disease drug, but fight for orphan treatment not over yet
Read more: Catalyst and Teva Pharmaceuticals settle patent dispute over rare-disease drug, but fight for orphan treatment not over yetNasadaq-listed Catalyst sees shares rise by 18% following the settlement, which grants Teva a license from February 2035.
-
UPC updates: Tesla settles with Broadcom; Dyson close to settling with SharkNinja; observations on December filings
Read more: UPC updates: Tesla settles with Broadcom; Dyson close to settling with SharkNinja; observations on December filingsBroadcom and Tesla have apparently settled their patent dispute. Dyson and SharkNinja appear to be close to settling their case. And some observations on UPC filings.
Follow Us
Latest Articles
- Adeia and RPX strike multilateral licensing deal for e-commerce patents
- Microsoft signs up to Sisvel Wi-Fi Multimode pool
- ASUS and Lenovo settle global SEP dispute
- Apple IPR petitions discretionarily denied due to differing constructions at PTAB and district court
- U.S. Supreme Court denies Finesse Wireless cert petition, snuffs out $166M verdict against AT&T